NASDAQ:SIEN - Sientra Stock Price, Forecast & News

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

Sientra Inc (NASDAQ:SIEN) posted its earnings results on Thursday, November, 7th. The medical instruments supplier reported ($0.45) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.47) by $0.02. The medical instruments supplier earned $22.41 million during the quarter, compared to analysts' expectations of $20.05 million. Sientra had a negative return on equity of 122.95% and a negative net margin of 143.76%. The firm's quarterly revenue was up 32.8% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.72) earnings per share. View Sientra's Earnings History.

Sientra is scheduled to release their next quarterly earnings announcement on Tuesday, March 10th 2020. View Earnings Estimates for Sientra.

Sientra issued an update on its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $23.2-23.2 million, compared to the consensus revenue estimate of $22.74 million.

8 equities research analysts have issued 1 year price targets for Sientra's stock. Their forecasts range from $10.00 to $27.00. On average, they anticipate Sientra's share price to reach $15.75 in the next year. This suggests a possible upside of 236.5% from the stock's current price. View Analyst Price Targets for Sientra.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sientra.

Media coverage about SIEN stock has trended extremely negative recently, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Sientra earned a daily sentiment score of -5.0 on InfoTrie's scale. They also assigned media coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Sientra.

Some companies that are related to Sientra include Establishment Labs (ESTA), RTI Surgical (RTIX), Invacare (IVC), Lakeland Industries (LAKE), ConforMIS (CFMS), COLLPLANT HOLDI/S (CLGN), Histogenics (HSGX), Allied Healthcare Products (AHPI), NanoVibronix (NAOV), Bionik Laboratories (BNKL), Rewalk Robotics (RWLK), Precision Therapeutics (POAI), Ocugen (OCGN) and Avitar (AVTI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Sientra investors own include Genocea Biosciences (GNCA), Verizon Communications (VZ), Novavax (NVAX), Rigel Pharmaceuticals (RIGL), Regions Financial (RF), Baidu (BIDU), ChemoCentryx (CCXI), Idera Pharmaceuticals (IDRA), Opko Health (OPK) and AbbVie (ABBV).

Sientra's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include UBS Group AG (4.84%), Schroder Investment Management Group (3.78%), Bamco Inc. NY (2.84%), Goldman Sachs Group Inc. (2.61%), Broadfin Capital LLC (2.60%) and UBS Asset Management Americas Inc. (2.16%). Company insiders that own Sientra stock include Jeffrey M Nugent, Keith J Sullivan, Patrick F Williams, Paul Sean Little, R Scott Greer and Timothy Haines. View Institutional Ownership Trends for Sientra.

SIEN stock was sold by a variety of institutional investors in the last quarter, including Broadfin Capital LLC, J. Goldman & Co LP, UBS Group AG, Barclays PLC, Bamco Inc. NY, Schroder Investment Management Group, Millrace Asset Group Inc. and Private Advisor Group LLC. View Insider Buying and Selling for Sientra.

SIEN stock was acquired by a variety of institutional investors in the last quarter, including Monarch Partners Asset Management LLC, EAM Investors LLC, Assenagon Asset Management S.A., EAM Global Investors LLC, State Street Corp, Marshall Wace North America L.P., Granite Point Capital Management L.P. and Bank of New York Mellon Corp. Company insiders that have bought Sientra stock in the last two years include Jeffrey M Nugent, Keith J Sullivan, Patrick F Williams, Paul Sean Little, R Scott Greer and Timothy Haines. View Insider Buying and Selling for Sientra.

Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SIEN stock can currently be purchased for approximately $4.68.

Sientra has a market capitalization of $231.58 million and generates $68.13 million in revenue each year. The medical instruments supplier earns $-82,630,000.00 in net income (profit) each year or ($3.25) on an earnings per share basis. Sientra employs 259 workers across the globe.View Additional Information About Sientra.

The official website for Sientra is http://www.sientra.com/.

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]